RedHill Biopharma Ltd.RDHLNASDAQ
Loading
Year-over-year debt growth rate
| Period | Value |
|---|---|
| Q2 2025 | 0.00% |
| Q1 2025 | -39.89% |
| Q4 2024 | 0.00% |
| Q3 2024 | -36.20% |
| Q2 2024 | 0.00% |
| Q1 2024 | -52.43% |
| Q4 2023 | 0.00% |
| Q3 2023 | -48.64% |
| Q2 2023 | -67.34% |
| Q1 2023 | -94.30% |
| Q4 2022 | 1.54% |
| Q3 2022 | 29.03% |
| Q2 2022 | -1.44% |
| Q1 2022 | 8.20% |
| Q4 2021 | -0.34% |
| Q3 2021 | 0.32% |
| Q2 2021 | 0.32% |
| Q1 2021 | 0.75% |
| Q4 2020 | 1.18% |
| Q3 2020 | 1.52% |
| Q2 2020 | 1.64% |
| Q1 2020 | 2081.81% |
| Q4 2019 | -3.37% |
| Q3 2019 | -3.00% |
| Q2 2019 | 32.70% |
| Q1 2019 | 0.00% |
| Q4 2018 | 0.00% |
| Q3 2018 | 0.00% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |
| Q4 2017 | 0.00% |
| Q3 2017 | 0.00% |
| Q2 2017 | 0.00% |
| Q1 2017 | 0.00% |
| Q4 2016 | 0.00% |
| Q3 2016 | 0.00% |
| Q2 2016 | 0.00% |
| Q1 2016 | 0.00% |
| Q4 2015 | 0.00% |
| Q3 2015 | 0.00% |